• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Pacira Pharm Inc (NQ: PCRX )

    17.15 -0.34 (-1.94%)
    Streaming Delayed Price Updated: 1:25 PM EDT, Oct 21, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Pacira Pharm Inc

    < Previous 1 2 3 4 5 6 Next >
    Pacira to Report Third Quarter 2023 Financial Results on Thursday November 2, 2023
    From Pacira BioSciences
    Via GlobeNewswire
    Analyst Expectations for Pacira BioSciences's Future
    Via Benzinga
    American Society of Anesthesiologists Announces New Industry Supporter Pacira BioSciences, Inc.
    From Pacira BioSciences
    Via GlobeNewswire
    Pacira BioSciences Appoints Four New Independent Directors to its Board of Directors
    From Pacira BioSciences
    Via GlobeNewswire
    4 Analysts Have This to Say About Pacira BioSciences
    Via Benzinga
    Analyst Ratings for Pacira BioSciences
    Via Benzinga
    Looking Into Pacira BioSciences's Return On Capital Employed
    Via Benzinga
    Recap: Pacira BioSciences Q1 Earnings
    Via Benzinga
    American Society of Anesthesiologists and Pacira BioSciences, Inc. Announce New Grant to Advance Education and Enhance Patient Care
    From Pacira BioSciences
    Via GlobeNewswire
    Pacira BioSciences Announces Leadership Succession Plan
    From Pacira BioSciences
    Via GlobeNewswire
    Pacira BioSciences Announces Fireside Chat at the H.C. Wainwright 25th Annual Global Investment Conference
    From Pacira BioSciences
    Via GlobeNewswire
    What 6 Analyst Ratings Have To Say About Pacira BioSciences
    Via Benzinga
    Stocks That Hit 52-Week Lows On Tuesday
      On Tuesday, 386 stocks made new 52-week lows. 
    Via Benzinga
    Stocks That Hit 52-Week Lows On Monday
      Monday's session saw 175 companies set new 52-week lows. 
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For August 3, 2023
    Via Benzinga
    Stocks That Hit 52-Week Lows On Friday
      Friday's session saw 225 companies set new 52-week lows. 
    Via Benzinga
    Pacira BioSciences Reports Second Quarter 2023 Financial Results
    From Pacira BioSciences
    Via GlobeNewswire
    Pacira to Report Second Quarter 2023 Financial Results on Wednesday August 2, 2023
    From Pacira BioSciences
    Via GlobeNewswire
    Pacira BioSciences to Participate in Fireside Chat at the 2023 Jefferies Healthcare Conference
    From Pacira BioSciences
    Via GlobeNewswire
    Pacira BioSciences to Participate in Fireside Chat at the 2023 RBC Capital Markets Global Healthcare Conference
    From Pacira BioSciences
    Via GlobeNewswire
    Why Pacira BioSciences Shares Are Trading Lower Today
    Pacira BioSciences Inc (NASDAQ: PCRX) reported Q1 sales of $160.3 million compared to $158.0 million a year ago and the  
    Via Benzinga
    Pacira BioSciences Reports First Quarter 2023 Financial Results
    From Pacira BioSciences
    Via GlobeNewswire
    Pacira to Report First Quarter 2023 Financial Results on Wednesday May 3, 2023
    From Pacira BioSciences
    Via GlobeNewswire
    Pacira BioSciences Partners with The Invited Celebrity Classic – a PGA TOUR Champions Event – to Make iovera° The Official Non-Opioid Pain Management Partner
    PGA TOUR Champions Golfer, Paul Goydos, Promotes Further Awareness of Non-Opioids with 2023 Partnership 
    From Pacira BioSciences
    Via GlobeNewswire
    Pacira BioSciences, Inc. Appoints Christopher Young as Chief Manufacturing Officer
    From Pacira BioSciences
    Via GlobeNewswire
    Pacira BioSciences to Participate in Fireside Chat at the 22nd Annual Needham Virtual Healthcare Conference
    From Pacira BioSciences
    Via GlobeNewswire
    Pacira BioSciences Announces Repayment and Termination of Term Loan B Facility Using Proceeds from New $150 Million 5-Year Term Loan A Facility and Existing Cash Resources
    From Pacira BioSciences
    Via GlobeNewswire
    Pacira Announces FDA Acceptance of sNDA for Exparel Nerve Blocks to Produce Regional Analgesia in Lower Extremity Procedures
    From Pacira BioSciences
    Via GlobeNewswire
    Third Circuit Court Upholds Decision to Dismiss Pacira BioSciences, Inc. Lawsuit
    From Pacira BioSciences
    Via GlobeNewswire
    Pacira BioSciences Announces Yvonne Greenstreet to Retire from Board of Directors
    From Pacira BioSciences
    Via GlobeNewswire
    < Previous 1 2 3 4 5 6 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.